Skip to content
AnalystLens

James Hardie Industries 8-K Report (Mar 6, 2026)

Filing Date
Filed March 6, 2026
Period End
March 6, 2026
Securities
JHXJHIUF
In the record · 2016–202610-K1210-Q28-K402

JHX filed 12 annual reports (10-K), 2 quarterly reports (10-Q) and 402 current reports (8-K) between 2016 and 2026.

Summary

Summary of the 6-K filed March 6, 2026. Cited figures are marked; the original filing is the authoritative source.

James Hardie Industries plc filed a Form 6-K containing three Australian Securities Exchange (ASX) notices dated March 5-6, 2026.

The filing is administrative in nature and reports equity issuances and securities on issue rather than operating or financial results. It contains no revenue, earnings, guidance, or dividend information. The two Appendix 3G notices (Exhibits 99.1 and 99.2) report the issuance of 10,440 ordinary shares on February 27, 2026 and 364 ordinary shares on March 2, 2026.

Each issuance was made at a cash price in US dollars, at USD 0.69670 and USD 0.69430 per share respectively. The filing states that the shares represent ordinary shares issued in respect of the settlement of certain AZEK equity awards outstanding at the closing of the merger, which was completed on July 1, 2025. The company applied for and received an ASX waiver from Listing Rule 2.4 for these unquoted issuances.

The Appendix 4A statement (Exhibit 99.3) reports CHESS Depositary Interests (CDIs) on issue of 430,438,730 at the end of February 2026, unchanged from the prior month. Unquoted securities at that date included 149,724,467 ordinary shares, 5,513,946 restricted stock units, and 269,221 options exercisable at USD 33.05 that expire on November 3, 2027. These figures show no month-over-month change for any category.

Key Highlights

  1. Issued 10,440 ordinary shares on February 27, 2026 at USD 0.69670 per share, related to settlement of AZEK equity awards following the July 1, 2025 merger.
  2. Issued 364 ordinary shares on March 2, 2026 at USD 0.69430 per share, under the same AZEK-related arrangement.
  3. CHESS Depositary Interests on issue totaled 430,438,730 at the end of February 2026, with no net change from the prior month.
  4. Unquoted ordinary shares on issue at end of February 2026 totaled 149,724,467, unchanged from the prior month.
  5. Restricted stock units outstanding totaled 5,513,946, and options exercisable at USD 33.05 totaled 269,221, expiring November 3, 2027; neither changed in February 2026.
  6. The company received an ASX waiver from Listing Rule 2.4 on July 16, 2025 for the unquoted securities issuances.

Frequently Asked Questions

  1. Why did James Hardie issue new ordinary shares in February and March 2026?

    The filing states that the shares were issued in respect of the settlement of certain AZEK equity awards that were outstanding at the closing of the merger with The AZEK Company Inc., which was completed on July 1, 2025.

  2. At what price were the shares issued?

    The 10,440 shares issued on February 27, 2026 were priced at USD 0.69670 per share, and the 364 shares issued on March 2, 2026 were priced at USD 0.69430 per share, each recorded as cash consideration in US dollars.

  3. Did the number of CDIs or ordinary shares on issue change in February 2026?

    No. The filing reports that CHESS Depositary Interests remained at 430,438,730 and unquoted ordinary shares remained at 149,724,467 at the end of February 2026, with no net difference from the previous month.

  4. What unquoted equity awards remain outstanding?

    The filing lists 5,513,946 restricted stock units and 269,221 options exercisable at USD 33.05 that expire on November 3, 2027, with no change in February 2026.